These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29483235)

  • 1. SMARCB1 Deficiency Integrates Epigenetic Signals to Oncogenic Gene Expression Program Maintenance in Human Acute Myeloid Leukemia.
    Chatterjee SS; Biswas M; Boila LD; Banerjee D; Sengupta A
    Mol Cancer Res; 2018 May; 16(5):791-804. PubMed ID: 29483235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation.
    Wang X; Lee RS; Alver BH; Haswell JR; Wang S; Mieczkowski J; Drier Y; Gillespie SM; Archer TC; Wu JN; Tzvetkov EP; Troisi EC; Pomeroy SL; Biegel JA; Tolstorukov MY; Bernstein BE; Park PJ; Roberts CW
    Nat Genet; 2017 Feb; 49(2):289-295. PubMed ID: 27941797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SWI/SNF Chromatin-remodeling Complex Status in SMARCB1/INI1-preserved Epithelioid Sarcoma.
    Kohashi K; Yamamoto H; Yamada Y; Kinoshita I; Taguchi T; Iwamoto Y; Oda Y
    Am J Surg Pathol; 2018 Mar; 42(3):312-318. PubMed ID: 29309303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MBD3/NuRD loss participates with KDM6A program to promote DOCK5/8 expression and Rac GTPase activation in human acute myeloid leukemia.
    Biswas M; Chatterjee SS; Boila LD; Chakraborty S; Banerjee D; Sengupta A
    FASEB J; 2019 Apr; 33(4):5268-5286. PubMed ID: 30668141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic roles of SMARCB1/INI1 and its deficient tumors.
    Kohashi K; Oda Y
    Cancer Sci; 2017 Apr; 108(4):547-552. PubMed ID: 28109176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MYC interaction with the tumor suppressive SWI/SNF complex member INI1 regulates transcription and cellular transformation.
    Stojanova A; Tu WB; Ponzielli R; Kotlyar M; Chan PK; Boutros PC; Khosravi F; Jurisica I; Raught B; Penn LZ
    Cell Cycle; 2016 Jul; 15(13):1693-705. PubMed ID: 27267444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of Snf5 Induces Formation of an Aberrant SWI/SNF Complex.
    Sen P; Luo J; Hada A; Hailu SG; Dechassa ML; Persinger J; Brahma S; Paul S; Ranish J; Bartholomew B
    Cell Rep; 2017 Feb; 18(9):2135-2147. PubMed ID: 28249160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting DCAF5 suppresses SMARCB1-mutant cancer by stabilizing SWI/SNF.
    Radko-Juettner S; Yue H; Myers JA; Carter RD; Robertson AN; Mittal P; Zhu Z; Hansen BS; Donovan KA; Hunkeler M; Rosikiewicz W; Wu Z; McReynolds MG; Roy Burman SS; Schmoker AM; Mageed N; Brown SA; Mobley RJ; Partridge JF; Stewart EA; Pruett-Miller SM; Nabet B; Peng J; Gray NS; Fischer ES; Roberts CWM
    Nature; 2024 Apr; 628(8007):442-449. PubMed ID: 38538798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular senescence regulated by SWI/SNF complex subunits through p53/p21 and p16/pRB pathway.
    He L; Chen Y; Feng J; Sun W; Li S; Ou M; Tang L
    Int J Biochem Cell Biol; 2017 Sep; 90():29-37. PubMed ID: 28716547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple interactions of the oncoprotein transcription factor MYC with the SWI/SNF chromatin remodeler.
    Woodley CM; Romer AS; Wang J; Guarnaccia AD; Elion DL; Maxwell JN; Guerrazzi K; McCann TS; Popay TM; Matlock BK; Flaherty DK; Lorey SL; Liu Q; Tansey WP; Weissmiller AM
    Oncogene; 2021 May; 40(20):3593-3609. PubMed ID: 33931740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRD9 defines a SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors.
    Wang X; Wang S; Troisi EC; Howard TP; Haswell JR; Wolf BK; Hawk WH; Ramos P; Oberlick EM; Tzvetkov EP; Ross A; Vazquez F; Hahn WC; Park PJ; Roberts CWM
    Nat Commun; 2019 Apr; 10(1):1881. PubMed ID: 31015438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary SWI/SNF complex deficiency syndromes.
    Agaimy A; Foulkes WD
    Semin Diagn Pathol; 2018 May; 35(3):193-198. PubMed ID: 29397238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of expression of the SWI/SNF complex is a frequent event in undifferentiated/dedifferentiated urothelial carcinoma of the urinary tract.
    Agaimy A; Bertz S; Cheng L; Hes O; Junker K; Keck B; Lopez-Beltran A; Stöckle M; Wullich B; Hartmann A
    Virchows Arch; 2016 Sep; 469(3):321-30. PubMed ID: 27339451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SWI/SNF Complex-deficient Undifferentiated/Rhabdoid Carcinomas of the Gastrointestinal Tract: A Series of 13 Cases Highlighting Mutually Exclusive Loss of SMARCA4 and SMARCA2 and Frequent Co-inactivation of SMARCB1 and SMARCA2.
    Agaimy A; Daum O; Märkl B; Lichtmannegger I; Michal M; Hartmann A
    Am J Surg Pathol; 2016 Apr; 40(4):544-53. PubMed ID: 26551623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smarcb1 maintains the cellular identity and the chromatin landscapes of mouse embryonic stem cells.
    Sakakura M; Ohta S; Yagi M; Tanaka A; Norihide J; Woltjen K; Yamamoto T; Yamada Y
    Biochem Biophys Res Commun; 2019 Nov; 519(4):705-713. PubMed ID: 31543342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SNF5/INI1 deficiency redefines chromatin remodeling complex composition during tumor development.
    Wei D; Goldfarb D; Song S; Cannon C; Yan F; Sakellariou-Thompson D; Emanuele M; Major MB; Weissman BE; Kuwahara Y
    Mol Cancer Res; 2014 Nov; 12(11):1574-85. PubMed ID: 25009291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of IGFBP7 expression and persistent AKT activation contribute to SMARCB1/Snf5-mediated tumorigenesis.
    Darr J; Klochendler A; Isaac S; Eden A
    Oncogene; 2014 Jun; 33(23):3024-32. PubMed ID: 23851500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleoporin 210 Serves a Key Scaffold for SMARCB1 in Liver Cancer.
    Hong SH; Son KH; Ha SY; Wee TI; Choi SK; Won JE; Han HD; Ro Y; Park YM; Eun JW; Nam SW; Han JW; Kang K; You JS
    Cancer Res; 2021 Jan; 81(2):356-370. PubMed ID: 33239431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic inactivation of the tumor suppressor BIN1 drives proliferation of SNF5-deficient tumors.
    McKenna ES; Tamayo P; Cho YJ; Tillman EJ; Mora-Blanco EL; Sansam CG; Koellhoffer EC; Pomeroy SL; Roberts CW
    Cell Cycle; 2012 May; 11(10):1956-65. PubMed ID: 22544318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulating the Expression Strength of the Baculovirus/Insect Cell Expression System: A Toolbox Applied to the Human Tumor Suppressor SMARCB1/SNF5.
    Golas MM; Jayaprakash S; Le LTM; Zhao Z; Heras Huertas V; Jensen IS; Yuan J; Sander B
    Mol Biotechnol; 2018 Nov; 60(11):820-832. PubMed ID: 30178299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.